our staff and customers remains our top priority. The Company constantly evaluate the situation and take proactive action to manage up-to-date under condition that are changing rapidly by aware of the
Analysis of Operating Results for the Company and its subsidiary Table 1: Overall Annual Operating Results for the year of 2018 and 2017 (Unit : Thousand Baht) Consolidated Financial Statements Separate
Separate Financial Statements Increase (Decrease) % 2018 2018 2017 Total revenues 1,626,468 1,544,670 1,644,433 (17,965) (1.1) Sales and service income 1,614,607 1,531,983 1,637,162 (22,555) (1.4) Cost of
Separate Financial Statements Increase (Decrease) % 2018 2018 2017 Total revenues 1,626,468 1,544,670 1,644,433 (17,965) (1.1) Sales and service income 1,614,607 1,531,983 1,637,162 (22,555) (1.4) Cost of
temporary close of operation and continually to evaluate each month situation. Investment plans according to the 2020 budget are also postponed in order to maintain the solvency of the cash flow. Loss on
Medical Business Plc., (CMR) amount Baht 1,010.31 million. comparing at the same period in 2017 representing 18.19% increase. Income from medical treatments in the separate financial went up 17.07% due to
Chiang Mai Ram Medical Business Plc., (CMR) amount Baht 995.22 million comparing at the same period in 2018 representing 1.86% increase . Income from medical treatments in the separate financial went up
ended September 30, 2019 To The President and Director The Stock Exchange of Thailand Dear Sirs, Finansia Syrus Securities Public Company would like to disclose the reviewed consolidated and separate
Medical Business Plc., (CMR) amount Baht 854.83 million. comparing at the same period in 2016 representing 3.30% increase. Income from medical treatments in the separate financial went down 3.46% due to the
Medical Business Pcl., (CMR) amount Baht 872.11 million. comparing at the same period in 2016 representing 8.11% increase. Income from medical treatments in the separate financial went up 4.19% due to the